Language Select
Varian Logo

Recent News

November 14, 2018
Varian (NYSE: VAR) today announced the publication of its annual Sustainability Report, detailing the company's initiatives and achievements in extending access to cancer care, protecting... Read more
November 05, 2018
On October 19th, 2018, IDC, the world's leading digital research firm, announced Beijing Cancer Hospital won a "2018 IDC China Digital Transformation Annual Award" in the category of Operating... Read more
October 23, 2018
Varian (NYSE: VAR) and GenesisCare, a leading provider of cancer care treatment, today announced the signing of a memorandum of understanding (MoU) to form a strategic partnership for cancer care... Read more

Recent Blog Posts

Nov 01, 2018 | Centerline
Advances in linear accelerator (LINAC) technology—including developments in image-guidance systems, multileaf collimators (MLCs), and volumetric arc therapy (VMAT) treatment delivery—have ushered in... Read more
Sep 19, 2018 | Centerline
In a new paper, “The Future of Cancer Care: Moving from Promise to Reality," Varian lays out the company’s vision for how advances in such disparate areas as diagnostics, genomics, precision... Read more
Aug 17, 2018 | Centerline
At Sírio-Libanês Hospital in São Paulo, Brazil, patients are now starting radiation treatment on average two days sooner. Reducing the time from simulation to the first day of treatment is just one... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com